Serge Turcaud - Concepedia

Author

Serge Turcaud

Centre National de la Recherche Scientifique

Also Known As

S Turcaud, S. TURCAUD, S. Turcaud, Serge Turcaud, Turcaud, S., Turcaud, Serge

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Centre National de la Recherche Scientifique Université Paris Cité Inserm Département de Pharmacochimie Moléculaire Délégation Paris 5

About

Serge Turcaud is an author at Centre National de la Recherche Scientifique specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	995
2	Natural Sciences	12	13	620
3	Engineering	8	8	208
4	Social Sciences	2	2	179
5	Anesthesia	1	1	53

Serge Turcaud

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Mixed-inhibitor-prodrug as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes Marie Claude Fournié-Zaluski, Pascale Coric, Serge Turcaud, Journal of Medicinal Chemistry Pharmaceutical SciencePharmacotherapyEnkephalin-degrading EnzymesChemical BiologyMedicinal Chemistry	1992	140
Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid δ and dopamine D1 receptor stimulation Ana Baamonde, Valérie Daugé, Mariano Ruiz‐Gayo, European Journal of Pharmacology Psychoactive DrugPsychiatryOpioid δMedicinePsychopharmacology	1992	125
Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats. Florence Noble, Jean-Marc Soleilhac, Evelyne Soroca-Lucas, Journal of Pharmacology and Experimental Therapeutics	1992	116
Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation Marie Claude Fournié-Zaluski, Pascale Coric, Serge Turcaud, Journal of Medicinal Chemistry Hot Plate TestMedicinal ChemistryAmino AcidsBiochemistryNatural Sciences	1992	88
New Dual Inhibitors of Neutral Endopeptidase and Angiotensin-Converting Enzyme: Rational Design, Bioavailability, and Pharmacological Responses in Experimental Hypertension Marie‐Claude Fournié‐Zaluski, Pascale Coric, Serge Turcaud, Journal of Medicinal Chemistry HypertensionBioorganic ChemistryCardiovascular PharmacologyPharmacotherapyIc50 Nep	1994	79
Design of Orally Active Dual Inhibitors of Neutral Endopeptidase and Angiotensin-Converting Enzyme with Long Duration of Action Marie‐Claude Fournié‐Zaluski, Pascale Coric, Vincent Théry, Journal of Medicinal Chemistry	1996	66
Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension. M C Fournié-Zaluski, Walter G. Gonzalez, Serge Turcaud, Proceedings of the National Academy of Sciences HypertensionCardiovascular PharmacologyPharmacotherapyBlood PressureOxidative Stress	1994	64
Development of Potent Inhibitors of Botulinum Neurotoxin Type B Christine Anne, Serge Turcaud, Jean Quancard, Journal of Medicinal Chemistry Medicinal ChemistryPotent ToxinsBioorganic ChemistryBiochemistryAntiparasitic Agent	2003	60
A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium. Jean-Marc Soleilhac, Edralin A. Lucas, Ann Beaumont, Molecular Pharmacology	1992	60
Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine Florence Noble, Serge Turcaud, Marie‐Claude Fournié‐Zaluski, European Journal of Pharmacology Mixed InhibitorPharmacologyNeuropathic PainMolecular PainNeuropharmacology	1992	56

Page 1